RNA INTERFERENCE (RNAI): AN EFFECTIVE WAY TO DEVELOP RATIONAL COMBINATION THERAPIES WITH HYPOMETHYLATING AGENTS IN ACUTE LEUKAEMIAS AND MYELODYSPLASTIC SYNDROME
Therapeutic progress in aggressive myeloid malignancies such as acute myeloid leukaemia (AML), myelodysplastic syndrome (MDS) and advanced myeloproliferative neoplasm (MPNs) has been slow. This is partially due to the heterogeneity of the diseases and the lack of molecular understanding, which delay...
| 主要作者: | |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
European Medical Journal
2013-08-01
|
| 丛编: | European Medical Journal Hematology |
| 主题: | |
| 在线阅读: | https://emj.emg-health.com/wp-content/uploads/sites/2/2013/08/EMJ-Hematology.-Raoul-Tibes..pdf |